Search
for
Sort by
Research 391–420 of 503
- Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
- Therapeutic potential of oral tofacitinib in alopecia areata: a retrospective study
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- 26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas
- Cetuximab Induced Hidrocystomas: A Case Report
- Skin reactions caused by epidermal growth factor receptor inhibitors and their management
- Treatment of acne with intermittent isotretinoin, cohort study
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
- Anti-Acne Agents Attenuate FGFR2 Signal Transduction in Acne
- Spectrum of skin diseases in Yemen (Hajjah and adjacent region)
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- Drug Eruptions
- Medications
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis
- Hair Loss in Women
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Current Status of Fractional Laser Resurfacing
- Systemic treatments for alopecia areata: A systematic review
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Transcriptomic analysis of human skin wound healing and rejuvenation following ablative fractional laser treatment
- Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis